| Dermatitis |
1 |
1 |
| Atopic Dermatitis |
0 |
0.99 |
| Biologic Therapy |
0 |
0.43 |
| Clinical Research |
0 |
0.37 |
| Eczema |
0 |
0.37 |
| Food and Drug Administration (FDA) |
0 |
0.37 |
| Thromboembolism |
0 |
0.36 |
| Otolaryngology |
0 |
0.32 |
| Europe |
0 |
0.25 |
| Pulmonary Embolism |
0 |
0.23 |
| Rheumatoid Arthritis |
0 |
0.23 |
| Headache |
0 |
0.21 |
| Asthma |
0 |
0.18 |
| Allergic Conjunctivitis |
0 |
0.17 |
| Alopecia Areata |
0 |
0.17 |
| Topical Corticosteroid |
0 |
0.17 |
| Deep Venous Thrombosis |
0 |
0.15 |
| Ocular Allergy |
0 |
0.15 |
| Airway |
0 |
0.12 |
| Alopecia |
0 |
0.12 |
| Arthritis |
0 |
0.12 |
| Atopy |
0 |
0.12 |
| Biomarker |
0 |
0.12 |
| Blood |
0 |
0.12 |
| Conjunctivitis |
0 |
0.12 |
| Corticosteroids |
0 |
0.12 |
| Embolism |
0 |
0.12 |
| Hand |
0 |
0.12 |
| Hospital |
0 |
0.12 |
| Interleukin |
0 |
0.12 |
| Leukopenia |
0 |
0.12 |
| Liver |
0 |
0.12 |
| Monoclonal Antibody |
0 |
0.12 |
| Nausea |
0 |
0.12 |
| Pain |
0 |
0.12 |
| Pruritus |
0 |
0.12 |
| Quality of Life |
0 |
0.12 |
| Receptors |
0 |
0.12 |
| Rhinitis |
0 |
0.12 |
| Sleep |
0 |
0.12 |
| Thrombosis |
0 |
0.12 |
| Vein |
0 |
0.12 |
| Cornea and External Disease |
0 |
0.11 |
| Inflammatory Bowel Disease |
0 |
0.11 |
| Pain Management |
0 |
0.11 |
| Skin and Soft Tissue Infection |
0 |
0.11 |